Efficacy and Safety of Medications for Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Network Meta-Analysis

被引:0
|
作者
Kendziora, Benjamin [1 ]
Frey, Jessica [2 ]
Reinholz, Markus [1 ]
Rueff, Franziska [1 ]
Oppel, Eva [1 ]
Zuberbier, Torsten [3 ]
Hartmann, Daniela [1 ]
Schlager, Justin Gabriel [1 ]
French, Lars [1 ]
机构
[1] LMU Klinikum, Klin & Poliklin Dermatol & Allergol, Munich, Germany
[2] Klinikum Rechts Isarder TU Munchen, Inst Diagnost Intervent Radiol, Munich, Germany
[3] Charite Univ Med Berlin, Inst Allergol, Berlin, Germany
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
P010
引用
收藏
页码:32 / 32
页数:1
相关论文
共 50 条
  • [11] Efficacy and safety of pharmacotherapy for refractory or unexplained chronic cough: a systematic review and network meta-analysis
    Zheng, Ziwen
    Huang, Junfeng
    Xiang, Ziyuan
    Wu, Tong
    Lan, Xiaoqing
    Xie, Shuojia
    Lin, Zikai
    Tang, Kailun
    Morice, Alyn
    Li, Shiyue
    Song, Woo-Jung
    Chen, Ruchong
    ECLINICALMEDICINE, 2023, 62
  • [12] Effectiveness and safety of Omatizumab in the treatment of chronic spontaneous urticaria: Systematic review and meta-analysis
    Rubini, N. P. M.
    Ensina, L. F. C.
    Silva, E. M. K.
    Sano, F.
    Sole, D.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2019, 47 (06) : 515 - 522
  • [13] Cyclosporine for Chronic Spontaneous Urticaria: A Meta-Analysis and Systematic Review
    Kulthanan, Kanokvalai
    Chaweekulrat, Pichanee
    Komoltri, Chulaluk
    Hunnangkul, Saowalak
    Tuchinda, Papapit
    Chularojanamontri, Leena
    Maurer, Marcus
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (02): : 586 - 599
  • [14] Efficacy and safety of Xiaofeng powder in the treatment of chronic urticaria: A systematic review and meta-analysis
    Bi, Chenhao
    Jia, Yuqi
    Wei, Fengqin
    MEDICINE, 2024, 103 (12) : E37305
  • [15] Comparison between chronic spontaneous urticaria and chronic induced urticaria on the efficacy of omalizumab treatment: A systematic review and meta-analysis
    He, Zhu-Han
    Qiu, Shuo-Cheng
    Huang, Zhi-Wei
    Zhang, Guo-Qiang
    An, Qing-Qing
    Qu, Feng
    Wang, Na
    DERMATOLOGIC THERAPY, 2022, 35 (12)
  • [16] Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
    Martin Metz
    Gordon Sussman
    Rémi Gagnon
    Petra Staubach
    Tonny Tanus
    William H. Yang
    Jeremy J. Lim
    Holly J. Clarke
    Joshua Galanter
    Leslie W. Chinn
    Tom Chu
    Anastasia Teterina
    Tracy Burgess
    D. James Haddon
    Timothy T. Lu
    Marcus Maurer
    Nature Medicine, 2021, 27 : 1961 - 1969
  • [17] Fenebrutinib in H1 antihistamine-refractory chronic spontaneous urticaria: a randomized phase 2 trial
    Metz, Martin
    Sussman, Gordon
    Gagnon, Remi
    Staubach, Petra
    Tanus, Tonny
    Yang, William H.
    Lim, Jeremy J.
    Clarke, Holly J.
    Galanter, Joshua
    Chinn, Leslie W.
    Chu, Tom
    Teterina, Anastasia
    Burgess, Tracy
    Haddon, D. James
    Lu, Timothy T.
    Maurer, Marcus
    NATURE MEDICINE, 2021, 27 (11) : 1961 - +
  • [18] Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis
    Liu Liu
    Huaibo Zhao
    Xiaoying Sun
    Qi Zheng
    Ying Luo
    Yi Ru
    Ying Zhang
    Xi Chen
    Bo Zhu
    Chengqian Yin
    Bin Li
    Xin Li
    BMC Complementary and Alternative Medicine, 18
  • [19] Efficacy and safety of Tripterygium wilfordii hook F for chronic urticaria: a systematic review and meta-analysis
    Liu, Liu
    Zhao, Huaibo
    Sun, Xiaoying
    Zheng, Qi
    Luo, Ying
    Ru, Yi
    Zhang, Ying
    Chen, Xi
    Zhu, Bo
    Yin, Chengqian
    Li, Bin
    Li, Xin
    BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 18
  • [20] Comparative efficacy and safety of the treatment by Omalizumab for chronic idiopathic urticaria in the general population: A systematic review and network meta-analysis
    Xu, Lan
    Yu, Han
    Xu, Shengxian
    Wang, Yingjun
    Cao, Yi
    SKIN RESEARCH AND TECHNOLOGY, 2024, 30 (05)